@article{97307534e3424669ac94190621ff94da,
title = "COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings",
abstract = "This study describes 94 patients who presented with suspected COVID-19 vaccine-related axillary adenopathy on breast imaging. All biopsies recommended within 12 weeks of the second vaccine dose were benign. Among women not recommended for biopsy, the median interval between the second vaccine dose and ultrasound follow-up was 15.9 weeks. Three biopsies yielding malignant diagnoses were recommended 12.0-13.1 weeks after the second vaccine dose. Lengthening imaging follow-up to 12-16 weeks after the second dose may reduce unnecessary biopsy recommendations.",
author = "Nguyen, {Derek L.} and Ambinder, {Emily B.} and Kelly Myers and Mullen, {Lisa A.} and Babita Panigrahi and Eniola Oluyemi",
note = "Funding Information: Submitted: Nov 24, 2021 Revision requested: Dec 6, 2021 Revision received: Dec 11, 2021 Accepted: Dec 14, 2021 First published online: Dec 22, 2021 The authors declare that they have no disclosures relevant to the subject matter of this article. Supported in part by research funding from the AUR GE Radiology Research Academic Fellowship to E. Oluyemi. An electronic supplement is available online at doi.org/10.2214/AJR.21.27162. Publisher Copyright: {\textcopyright} 2022 American Roentgen Ray Society. All rights reserved.",
year = "2022",
month = jun,
doi = "10.2214/AJR.21.27162",
language = "English (US)",
volume = "218",
pages = "997--998",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",
}